Phase I open-label single-arm study of dual targeting BCMA and CD19 FasTCAR-T cells (GC012F) as first-line therapy for transplant-eligible newly diagnosed high-risk multiple myeloma

Juan Du,Wanting Qiang,Jing Lu, Yanchun Jia,Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng,Lina Jin, Xiaoqiang Fan,Jia Liu,Qi Zhang,Lianjun Shen,Lihong Weng, Wenling Li,Wei Cao

Blood（2023）

引用 6|浏览16

暂无评分

关键词

multiple myeloma,cd19,open-label,single-arm,first-line,transplant-eligible,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要